Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Venous Thrombosis

  Free Subscription


1 J Vasc Interv Radiol
1 PLoS One
2 Thromb Haemost
2 Thromb Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    J Vasc Interv Radiol

  1. WADHWA V, Trivedi PS, Chatterjee K, Desai S, et al
    Identifying Patient and Hospital Characteristics Resulting in Higher Use of Inferior Vena Cava Filters among Inpatients with Venous Thromboembolic Disease: Analysis of the 2014 Nationwide Inpatient Sample.
    J Vasc Interv Radiol. 2018;29:1206-1208.
    PubMed     Text format    

    PLoS One

  2. GROSSE A, Grosse C, Lang I
    Evaluation of the CT imaging findings in patients newly diagnosed with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0201468.
    PubMed     Text format     Abstract available

    Thromb Haemost

  3. KRAAIJPOEL N, Di Nisio M, Mulder FI, van Es N, et al
    Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
    Thromb Haemost. 2018;118:1439-1449.
    PubMed     Text format     Abstract available

  4. JIMENEZ D, Bikdeli B
    Scores to Identify Occult Cancer in Venous Thromboembolism: Do They Work?
    Thromb Haemost. 2018;118:1343-1344.
    PubMed     Text format    

    Thromb Res

  5. KUNUTSOR SK, Beswick AD, Whitehouse MR, Blom AW, et al
    Systematic review of risk prediction scores for venous thromboembolism following joint replacement.
    Thromb Res. 2018;168:148-155.
    PubMed     Text format     Abstract available

  6. PRANDONI P, Lensing AWA, Prins MH, Gebel M, et al
    Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
    Thromb Res. 2018;168:121-129.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.